cbdMD (NYSEAMERICAN:YCBD) Shares Down 1.6% – Should You Sell?

Shares of cbdMD, Inc. (NYSEAMERICAN:YCBD) traded down 1.6% on Thursday. The stock traded as low as $0.3622 and last traded at $0.3728. Approximately 74,629 shares were traded during trading, a decline of 16% from the average session volume of 89,154 shares. The stock had previously closed at $0.3789.

Wall Street Analysts Forecast Growth

Separately, Maxim Group cut shares of cbdMD from a “buy” rating to a “hold” rating in a report on Monday, August 17th. One analyst has rated the stock with a Hold rating. According to MarketBeat, the company has a consensus rating of “Hold”.

cbdMD Price Performance

The firm has a fifty day moving average of $0.45 and a 200-day moving average of $0.62.

cbdMD (NYSEAMERICAN:YCBD) last issued its quarterly earnings data on Thursday, August 13th. The company reported ($0.11) EPS for the quarter, missing analysts’ consensus estimates of ($0.03) by ($0.08). cbdMD had a negative return on equity of 34.26% and a negative net margin of 13.80%. The company had revenue of $5.55 million for the quarter, compared to the consensus estimate of $5.69 million.

cbdMD Company Profile

cbdMD, Inc (NYSE American: YCBD) is a consumer health and wellness company that develops, markets and sells hemp-derived cannabinoid products. Its offerings have included cannabidiol (CBD) oils and tinctures, gummies and other ingestible products, capsules, creams and lotions, as well as products formulated for sleep, recovery and general wellness.

The company also markets CBD products for pets and has expanded its portfolio to include additional cannabinoid-based and functional wellness products.